159 related articles for article (PubMed ID: 36999196)
21. The mechanism of epithelial-mesenchymal transition induced by TGF-β1 in neuroblastoma cells.
Shao JB; Gao ZM; Huang WY; Lu ZB
Int J Oncol; 2017 May; 50(5):1623-1633. PubMed ID: 28393230
[TBL] [Abstract][Full Text] [Related]
22. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium.
Yao Y; Chen R; Wang G; Zhang Y; Liu F
Stem Cell Res Ther; 2019 Jul; 10(1):225. PubMed ID: 31358049
[TBL] [Abstract][Full Text] [Related]
23. Numb-PRRL promotes TGF-β1- and EGF-induced epithelial-to-mesenchymal transition in pancreatic cancer.
Sheng W; Tang J; Cao R; Shi X; Ma Y; Dong M
Cell Death Dis; 2022 Feb; 13(2):173. PubMed ID: 35197444
[TBL] [Abstract][Full Text] [Related]
24. Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.
Zhang LL; Jiang XM; Huang MY; Feng ZL; Chen X; Wang Y; Li H; Li A; Lin LG; Lu JJ
Phytomedicine; 2019 Jan; 52():32-39. PubMed ID: 30599910
[TBL] [Abstract][Full Text] [Related]
25. Babao Dan inhibits the migration and invasion of gastric cancer cells by suppressing epithelial-mesenchymal transition through the TGF-β/Smad pathway.
Liu J; Chen Y; Cao Z; Guan B; Peng J; Chen Y; Zhan Z; Sferra TJ; Sankararaman S; Lin J
J Int Med Res; 2020 Jun; 48(6):300060520925598. PubMed ID: 32529872
[TBL] [Abstract][Full Text] [Related]
26. Verbascoside inhibits the epithelial-mesenchymal transition of prostate cancer cells through high-mobility group box 1/receptor for advanced glycation end-products/TGF-β pathway.
Wu CH; Chen CH; Hsieh PF; Lee YH; Kuo WW; Wu RC; Hung CH; Yang YL; Lin VC
Environ Toxicol; 2021 Jun; 36(6):1080-1089. PubMed ID: 33522686
[TBL] [Abstract][Full Text] [Related]
27. Bone mesenchymal stem cells promote gastric cancer progression through TGF-β1/Smad2 positive feedback loop.
Fan M; Zhang Y; Shi H; Xiang L; Yao H; Lin R
Life Sci; 2023 Jun; 323():121657. PubMed ID: 37019301
[TBL] [Abstract][Full Text] [Related]
28. Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways.
Li W; Mao Y; Hua B; Gu X; Lu C; Xu B; Pan W
Pharm Biol; 2022 Dec; 60(1):1865-1875. PubMed ID: 36205544
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer.
Huo W; Zhu XM; Pan XY; Du M; Sun Z; Li ZM
Math Biosci Eng; 2019 May; 16(5):4607-4621. PubMed ID: 31499680
[TBL] [Abstract][Full Text] [Related]
30. KLF8 is activated by TGF-β1 via Smad2 and contributes to ovarian cancer progression.
Cherukunnath A; Davargaon RS; Ashraf R; Kamdar U; Srivastava AK; Tripathi PP; Chatterjee N; Kumar S
J Cell Biochem; 2022 May; 123(5):921-934. PubMed ID: 35293014
[TBL] [Abstract][Full Text] [Related]
31. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
[TBL] [Abstract][Full Text] [Related]
32. CISD2 promotes lung squamous carcinoma cell migration and invasion via the TGF-β1-induced Smad2/3 signaling pathway.
Zhang J; Pan L; Zhang S; Yang Y; Liang J; Ma S; Wu Q
Clin Transl Oncol; 2023 Dec; 25(12):3527-3540. PubMed ID: 37249759
[TBL] [Abstract][Full Text] [Related]
33. microRNA-141 inhibits TGF-β1-induced epithelial-to-mesenchymal transition through inhibition of the TGF-β1/SMAD2 signalling pathway in endometriosis.
Wang S; Zhang M; Zhang T; Deng J; Xia X; Fang X
Arch Gynecol Obstet; 2020 Mar; 301(3):707-714. PubMed ID: 31903498
[TBL] [Abstract][Full Text] [Related]
34. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway.
Tang Y; Liu Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
BMC Cancer; 2024 Feb; 24(1):204. PubMed ID: 38350902
[TBL] [Abstract][Full Text] [Related]
35. Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.
Choi YJ; Baek GY; Park HR; Jo SK; Jung U
PLoS One; 2016; 11(1):e0147343. PubMed ID: 26799321
[TBL] [Abstract][Full Text] [Related]
36. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin Inhibited the EMT of Pancreatic Cancer Cells by Mediating the TGF-β/Smad Signaling Pathway.
Zhou X; Wang W; Liu L
Discov Med; 2023 Dec; 35(179):1086-1092. PubMed ID: 38058074
[TBL] [Abstract][Full Text] [Related]
38. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
[TBL] [Abstract][Full Text] [Related]
39. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
40. WISP1 aggravates cell metastatic potential by abrogating TGF-
Song D; Wang L; Su K; Wu H; Li J
Exp Biol Med (Maywood); 2021 Jun; 246(11):1244-1252. PubMed ID: 33593111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
